"Spanish scientist finds cure for pancreatic cancer in major medical breakthrough"
"The CNIO therapy takes a different approach. Instead of attacking one pathway, it combines three drugs to shut down multiple tumour survival mechanisms simultaneously. According to the researchers, this strategy prevents cancer cells from rewiring themselves, a common cause of treatment failure."
Spanish scientist finds cure for pancreatic cancer in major medical breakthrough | - The Times of India https://share.google/an37A70EAz25rVu2G
This article could have been written about Leronlimab and mTNBC (metastatic Triple Negative Breast Cancer). They are using the word, cure, based on animal studies. Leronlimab also works on multiple pathways to stop metastasis and destroy tumors. Plus, Leronlimab has been used in people, and is well tolerated with very little side effects. Personally, I think Leronlimab, with a properly structured protocol, coupled with a complementary drug combination, would be quite effective against pancreatic cancer in patients that exhibit high CCR5 expression. Have we completed any murine studies?
"The CNIO therapy takes a different approach. Instead of attacking one pathway, it combines three drugs to shut down multiple tumour survival mechanisms simultaneously. According to the researchers, this strategy prevents cancer cells from rewiring themselves, a common cause of treatment failure."
Spanish scientist finds cure for pancreatic cancer in major medical breakthrough | - The Times of India https://share.google/an37A70EAz25rVu2G
This article could have been written about Leronlimab and mTNBC (metastatic Triple Negative Breast Cancer). They are using the word, cure, based on animal studies. Leronlimab also works on multiple pathways to stop metastasis and destroy tumors. Plus, Leronlimab has been used in people, and is well tolerated with very little side effects. Personally, I think Leronlimab, with a properly structured protocol, coupled with a complementary drug combination, would be quite effective against pancreatic cancer in patients that exhibit high CCR5 expression. Have we completed any murine studies?
10
